Furthermore, TP53 inactivation has been identified in tumor progression, metastasis, and aggressive phenotype of bladder cancer giving rise to what has been considered as a useful genetic biomarker to predict progression associated with bad prognosis [9-11]. Here, TP53 is linked to urinary bladder cancer.